NAG kit
Robinson D and Stirling JL (1968)
N-Acetyl-b-D-glucosaminidase in human Spleen. Biochem J, 107, 321-327.
Swallow DM, Stokes DC, Corney C and Harris H (1974)
Yuen C-T, Price RG, Richardson AC and Praill PFG (1981)
The assay of arylesterase in serum using two new colorimetric substrates, w-nitro styryl acetate and propionate. Clin Chim Acta, 112, 99-105.
Yuen C-T, Price RG, Chattagoon L, Richardson AC and Praill PFG (1982)
Yuen C-T, Kind PRN, Price RG, Praill PFG and Richardson AC (1984)
Dewji NN, De Keyser DR and Stirling JL (1986)
Taylor SA, Richardson AC, Praill PFG and Price RG (1990)
A new colorimetric kit for the assay of N-acetyl-ß-glucosaminidase in urine. Clin Chem News, 16, 24-26.
Posci I, Taylor SA, Richardson AC, Aamlid KH, Smith BV and Price RG (1990)
Price RG (1991)
New colorimetric substrates for the assay of hydrolytic enzymes: N-acetyl-ß-D-glucosaminidase (NAG) – an improved test for the assessment of renal disease. A Review. CHEMISTRY TODAY (CHIMMICA oggi), 6, 15-19.
Pocsi I, Csathy L, Olah V A, Price RG (1991)
Price RG (1992)
Price RG (1992)
The measurement of Urinary N-acetyl-ß-D-glucosaminidase (NAG) and its isoenzymes, Methods and Clinical Applications. Eur J Clin Chem Clin Biochem, 30, 693-705.
Mueller PW, Price RG and Porter GA (1997)
Skalova S (2005)
Liangos O., Perianayagam MC., Vaidya VS. et al, (2007)
Sheira G., Noreldin N., Tamer A. and Saad M (2015)
Letizia Zeni, Anthony G. W. Norden, Giovanni Cancarini and Robert J. Unwin (2017)
Zalewska-Szajada et al (2018)
Diphencyprone
Hoffmann R, Wenzel E, Huth A van der Steen P, Schaufel M, Henninger HP and Happle R. (1994)
Buckley DA, Keane FM, Munn SE, Fuller LC, Higgins EM and du Vivier AWP (1999)
Sterling JC, Handfield-Jones S and Hudson PM (2000)
Guidelines for the management of cutaneous warts. Brit J dermatology, 144, 4-11.
Happle R (2002)
Diphencyprone for the treatment of Alopaecia areata, more data and new aspects [Editorial]. Arch Dermatol, 138, 1123-113.
Higgins E and du Vivier A (2002)
Topical immunotherapy: Unapproved uses, dosages or indications. Clinics in dermatology, 20, 515-521.
Trefzer U and Sterry W (2005)
Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma. Dermatology, 211,370-371.
Damian DL and Johnson JF (2007)
Damian DL, Shannon KF, Saw RP and Thompson JF (2009)
Martindale (2009)
The complete Drug Reference, Dermatological Drugs and sunscreens, Diphencyprone (Sweetman S, Ed) London Pharmaceutical Press., 35th Edition.
El-Zawahry B, Bassiouny D, Khella A and Zaki N (2010)
Singh G and Lavanya MS (2010)
Topical Immunotherapy in Alopecia areata. Int J Trichology, 2(1), 36-39.
Salsberg JM and Donovan J (2012)
Kim YJ (2012)
Kutty A, Harper F and Akhras V (2013)
El-Zawahry BM, Azzam OA, Zaki NS, Abdel-Raheem HM, Bassiouny DA and Khorshied MM (2013)
Audrain H, Siddiqui H and Buckley DA (2013)
Microbiology
General
Sanchez-Bernal CS, Robinson G, Miles RJ and Price RG (1994)
Development of a sensitive and quantitative enzyme-linked immunofilter assay (ELIFA) for whole bacterial cells. J Microbiol Meth, 19, 135-143.
Paffard SM, Miles RJ, Clark CR and Price RG (1996)
A sensitive forty minute enzyme linked immunofilter assay (ELIFA) for whole bacterial cells. J Immunol Meth, 192, 133-136.
Paffard SM, Miles RJ, Clark CR and Price RG (1997)
Candida
Cooke VM, Miles RJ, Price RG, Midgley G, Khamri W and Richardson AC (2002)
Coliforms
Browne NK, Huang Z, Dockrell M, Hashmi P and Price RG (2009)
Mycoplasma
Khan L, Richardson AC, Price RG, Nicholas R and Miles R (2000)
A chromogenic substrate for the rapid detection of Mycoplasma agalactiae and Mycoplasma bovis. 13th Congress of the International Organisation for Mycoplasmology (Abstract) P-L21.
Salmonella
Cooke VM, Miles RJ, Price RG and Richardson AC (1999)
Substrates
General
Aamlid KH, Lee G, Price RG, Richardson AC, Smith BV and Taylor SA (1989)
Development of improved chromogenic substrates for the detection and assay of hydrolytic enzymes. Chem & Ind, 106-108.
Aamlid KH, Lee G, Smith BV, Richardson AC and Price RG (1990)
New colorimetric substrates for the assay of glycosidases. Carbohydrate Res, 205, C5-C9.
Posci I, Taylor SA, Richardson AC, Aamlid KH, Smith BV and Price RG (1990)
Galactosidase
Bainbridge BW, Mathias N, Price RG, Richardson AC, Sandhu J and Smith BV (1991)
Pocsi I, Taylor SA, Richardson AC, Smith BV and Price RG. (1993)
Esterase/lipase
Yuen C-T, Price RG, Richardson AC and Praill PFG (1981)
The assay of arylsterase in serum using two new colorimetric substrates, w-nitrostyrylacetate and propionate. Clin. Chim. Acta, 112, 99-105.
Miles RJ, Siu ELT, Carrington C, Richardson AC, Smith BV and Price RG (1992)
Biomarkers
Price RG (2000)
Urinalysis to exclude and monitor nephrotoxicity. Clin Chim Acta 297, 173-182.
Whiting PH and Price RG (2001)
Importance of early detection of renal dysfunction: value of markers of early renal disease and damage. Clinical Biochemistry, 3(1), 3-8.
Olah AC, Price RG, Csathy L, Orszagh E, Olah E and Varga J (2004)
Age dependence of serum ß-N-acetylhexosaminidase (NAG). Clin Chem Lab Med. 42, 305-306.
Hart SGE (2005)
Assessment of renal injury in vivo. J Pharmacological and Toxicological. Methods, 52, 30-45.
Coca SG, Yalavarthy R, Concato J and Parikh CR (2008)
Biomarkers for the diagnosis and risk stratification of cutee kidney injury: A systematic review. Kidney Int. 73(9), 1008-1016.
Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P and Bonventre JV (2008)
Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 73, 863-869.